AccessMED is uniquely positioned to help pharmaceutical manufacturers increase patient access and improve product utilization by addressing reimbursement barriers. Our support often begins in the pre-launch phase, a year or more before the anticipated marketing launch, and continues well into a product’s maturity. We address complex challenges in the marketplace by providing expertise in the following areas: • Strategic Product Consulting • Patient Assistance Programs • Reimbursement Services • Patient Relationship Management AccessMED is a wholly owned subsidiary of US Oncology. This status provides us with real-world learnings from the largest community-based network of affiliated oncologists. Additionally, we have gained vast knowledge about the ecosystem of patients, prescribers, payers, and manufacturers, that translates well from oncology-specific therapies to any other prescribed therapy with complex program guidelines or administration requirements (such as drugs that must be administered “in-office”).